PHE have updated the Musculoskeletal Diseases profile today to include four new indicators and four updated time points for 2016/17. Continue reading
Quality Standards for Osteoporosis and Prevention of Fragility Fractures
Identifying vertebral fractures systematically has proven challenging for all clinicians and currently more than two-thirds are undiagnosed. The purpose of this guidance is to ensure that all vertebral fractures are systematically identified, reported using clear terminology to the referring clinician and lead to appropriate management to avoid further fragility fractures.
Clinical Guidance for the Effective Identification of Vertebral Fractures
Derived from current guidance, these seven standards reflect high-quality practice across the fracture prevention pathway. Detailed criteria and measures are included to allow evaluation of service performance. They provide the foundation for Peer Review of osteoporosis services.
Bisphosphonates in primary care: starting, reviewing and stopping
In this interactive webinar, the GP and rheumatologist presenters, acknowledging the multiplicity of guidance on osteoporosis management, present a pragmatic approach to risk assessment, treatment initiation, patient reviews, and drug ‘holidays’ or cessation. A reference flowchart and potential targets for audit is also provided.
Watch back this hour long webinar for Primary Care professionals for FREE. Presented by Dr Kevin Fernando, GP, this webinar covers:
1) Modifiable and non-modifiable risk factors for osteoporosis.
2) QFracture & FRAX for fracture risk assessment and who to refer for DXA.
3) Management of osteoporosis and prevention of fragility fractures using a
case study. Who to treat?
4) The role of calcium & vitamin D in bone health.
5) Multimorbidity, frailty, bisphosphonates and vitamin D.
Gain CPD accreditation by completing theRoyal College of General Practitioners (RCGP) and National Osteoporosis Society’s e-learning osteoporosis module. This half-hour e-learning module will test your knowledge of osteoporosis management including:
– identifying high risk patients
– when to initiate treatment
– how often to monitor patients
This guideline covers diagnosing and managing spondyloarthritis that is suspected or confirmed in adults who are 16 years or older. It aims to raise awareness of the features of spondyloarthritis and provide clear advice on what action to take when people with signs and symptoms first present in healthcare settings. It also provides advice on the range of treatments available.
This course aims to educate GPs about Axial Spondyloarthritis (SpA). The first session will cover the presentation, including which clinical features in patients with back pain should raise suspicion of SpA. A case study will illustrate key features in the history and examination, how to investigate in primary care and the criteria for referral to secondary care. The second session discusses management and the wider impact of SpA, including effects on employment. Co-authored by BRITSpA and NASS.